5WR0
Huisgen cycloaddition for PPARg-LBD labeling by soaking method
Summary for 5WR0
Entry DOI | 10.2210/pdb5wr0/pdb |
Descriptor | Peroxisome proliferator-activated receptor gamma, (E)-N-[(3E)-2-oxo-16-(8-{6-[(trifluoroacetyl)amino]hexanoyl}-8,9-dihydro-1H-dibenzo[b,f][1,2,3]triazolo[4,5-d]azocin-1-yl)hexadec-3-en-1-ylidene]glycine (3 entities in total) |
Functional Keywords | receptor, transcription |
Biological source | Homo sapiens (Human) |
Cellular location | Nucleus: P37231 |
Total number of polymer chains | 2 |
Total formula weight | 63663.92 |
Authors | Kojima, H.,Itoh, T.,Yamamoto, K. (deposition date: 2016-11-29, release date: 2017-11-22, Last modification date: 2024-11-20) |
Primary citation | Kojima, H.,Itoh, T.,Yamamoto, K. On-site reaction for PPAR gamma modification using a specific bifunctional ligand Bioorg. Med. Chem., 25:6492-6500, 2017 Cited by PubMed Abstract: Site-specific labeling is an important methodology to elucidate the biological function of a target protein. Here, we report a strategy for site-specific chemical labeling, termed the "on-site reaction". We designed and readily synthesized a bifunctional ligand possessing two reaction sites, an enone and an azide moiety. This strategy involves an on-site conjugate addition reaction with protein followed by a Hüisgen cycloaddition reaction. We demonstrate this strategy by using fluorescein as a probe and peroxisome proliferator activated receptor γ (PPARγ) as a target protein. The reactions were evaluated by ESI-mass analysis and the binding site and modes of binding were revealed by X-ray crystallization analysis. The proposed methodology can easily convert a covalent ligand into chemical tool for protein functional analysis and the identification of drug targets. PubMed: 29097031DOI: 10.1016/j.bmc.2017.10.024 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.85 Å) |
Structure validation
Download full validation report
